130 related articles for article (PubMed ID: 25884471)
21. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
22. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
[TBL] [Abstract][Full Text] [Related]
23. Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer.
Kelland LR; Smith V; Valenti M; Patterson L; Clarke PA; Detre S; End D; Howes AJ; Dowsett M; Workman P; Johnston SR
Clin Cancer Res; 2001 Nov; 7(11):3544-50. PubMed ID: 11705875
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
Ciardiello F; Bianco R; Damiano V; De Lorenzo S; Pepe S; De Placido S; Fan Z; Mendelsohn J; Bianco AR; Tortora G
Clin Cancer Res; 1999 Apr; 5(4):909-16. PubMed ID: 10213228
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.
Saracco A; Szabó BK; Aspelin P; Leifland K; Tánczos E; Wilczek B; Axelsson R
Acta Radiol; 2015 Jan; 56(1):34-41. PubMed ID: 24445092
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
[TBL] [Abstract][Full Text] [Related]
27. [Differential anti-tumor effects for various regimens of endostar plus cisplatin in ovarian cancer].
Xin G; Du J; Zhu L; Yu YH; Li Y; Liu PS
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(47):3367-70. PubMed ID: 22333207
[TBL] [Abstract][Full Text] [Related]
28. [Inhibitory effect of compound cantharides capsule on the proliferation of xenografts of human hepatocellular carcinoma HepG(2)215 in mice].
Han JJ; Yu JM; Wu HY; Liu JB; Song B; Xue DW
Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):821-5. PubMed ID: 23291129
[TBL] [Abstract][Full Text] [Related]
29. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
Cao X; Xue J; Zhao B
Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
[TBL] [Abstract][Full Text] [Related]
30. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
31. Early chemotherapy response evaluation in tumors by 99mTc-DTPA-DG.
Liang J; Chen Y; Huang Z; Zhao Y; He L
Cancer Biother Radiopharm; 2008 Jun; 23(3):363-70. PubMed ID: 18593369
[TBL] [Abstract][Full Text] [Related]
32. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
33. Comparison of superb microvascular imaging (SMI) quantified with ImageJ to quantified contrast-enhanced ultrasound (qCEUS) in liver metastases-a pilot study.
Kratzer W; Güthle M; Dobler F; Seufferlein T; Graeter T; Schmidberger J; Barth TF; Klaus J
Quant Imaging Med Surg; 2022 Mar; 12(3):1762-1774. PubMed ID: 35284256
[TBL] [Abstract][Full Text] [Related]
34. Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model.
Kramer-Marek G; Gijsen M; Kiesewetter DO; Bennett R; Roxanis I; Zielinski R; Kong A; Capala J
J Nucl Med; 2012 Apr; 53(4):629-37. PubMed ID: 22410461
[TBL] [Abstract][Full Text] [Related]
35. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of erlotinib in combination with capecitabine in human tumor xenograft models.
Ouchi KF; Yanagisawa M; Sekiguchi F; Tanaka Y
Cancer Chemother Pharmacol; 2006 May; 57(5):693-702. PubMed ID: 16362295
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
Song KD; Choi D; Lee JH; Im GH; Yang J; Kim JH; Lee WJ
AJR Am J Roentgenol; 2014 Jun; 202(6):W559-66. PubMed ID: 24848850
[TBL] [Abstract][Full Text] [Related]
38. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts.
Burke PA; DeNardo SJ; Miers LA; Lamborn KR; Matzku S; DeNardo GL
Cancer Res; 2002 Aug; 62(15):4263-72. PubMed ID: 12154028
[TBL] [Abstract][Full Text] [Related]
39. Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.
Blumenthal RD; Waskewich C; Goldenberg DM; Lew W; Flefleh C; Burton J
Clin Cancer Res; 2001 Oct; 7(10):3178-85. PubMed ID: 11595712
[TBL] [Abstract][Full Text] [Related]
40. Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts.
Staffhorst RW; van der Born K; Erkelens CA; Hamelers IH; Peters GJ; Boven E; de Kroon AI
Anticancer Drugs; 2008 Aug; 19(7):721-7. PubMed ID: 18594214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
